Skip to content
Lygos logo

Lygos

Lygos is a YC Winter 2016 (W16) company. Based in San Francisco, CA, USA. Team of 55.

  • Synthetic Biology
  • Climate
  • Biotechnology

About Lygos

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Lygos engineers microbes, primarily yeast, to produce high-value industrial chemicals from sugar. The process targets compounds where biological fermentation undercuts the cost of conventional petrochemical manufacturing. Customers in industries such as healthcare, materials, and specialty chemicals get a renewable supply chain alternative to fossil-fuel-derived inputs.

From the Y Combinator listing

How Lygos describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Lygos engineers yeast to convert sugar into high-value industrial…

Founded in 2010, Lygos is providing biotechnology solutions for today’s renewable chemical challenges. They engineer microbes to convert sugars into high-value, industrial chemicals, targeting compounds where biological production is cost-advantaged over petrochemical production.

Facts

Industry
Healthcare / Healthcare -> Industrial Bio
Location
San Francisco, CA, USA
Team size
55
Status
Active
Stage
Growth

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works